Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France
Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France
Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population
Inclusion Criteria:
Exclusion Criteria:
- There are no exclusion criteria, except for the patient's explicit refusal to participate
sophie.caillard@chru-strasbourg.fr33 3 69 55 13 20
said.chayer@chru-strasbourg.fr33 3 88 11 66 90
Strasbourg, 67091, France
sophie.caillard@chru-strasbourg.fr33 3 69 55 13 20
samira.fafi-kremer@chru-strasbourg.fr33 3 69 55 14 38